Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder-Reference-Cited by-同舟云学术

Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder

Published:2015-08 Issue:8 Volume:25 Page:1082-1090
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Abdallah Chadi G.,Jackowski Andrea,Sato João R.,Mao Xiangling,Kang Guoxin,Cheema Raminder,Coplan Jeremy D.,Mathew Sanjay J.,Shungu Dikoma C.

Funder

National Institutes of Health

CFIDS Association of America, Inc (DCS)

Weill Cornell Medical College New Faculty Development Funds (DCS)

NIDA

Clinical Neurosciences Division of the VA National Center for Posttraumatic Stress Disorder, the Brain & Behavior Research Foundation (NARSAD New Investigator Award—Vital Projects Fund Inc. Investigator)

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference50 articles.

1. A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD;Abdallah;Eur. Neuropsychopharmacol.,2013

2. Hippocampal volume and the rapid antidepressant effect of ketamine;Abdallah;J. Psychopharmacol.,2014

3. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study;Auer;Biol. Psychiatry,2000

4. Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole;Banasr;Mol. Psychiatry,2010

5. Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients;Bhagwagar;Int. J. Neuropsychopharmacol.,2008

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Gut Microbiota and Major Depressive Disorder: Current Understanding and Novel Therapeutic Strategies;Current Pharmaceutical Biotechnology;2024-12

2. Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses;2024-07-30

3. Astroglial Dysfunctions in Mood Disorders and Rodent Stress Models: Consequences on Behavior and Potential as Treatment Target;International Journal of Molecular Sciences;2024-06-08

4. Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study;International Journal of Molecular Sciences;2023-12-20

5. Menin Reduces Parvalbumin Expression and is Required for the Anti‐Depressant Function of Ketamine;Advanced Science;2023-12-03